Means Investment Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.76M | Sell |
22,908
-513
| -2% | -$110K | 0.44% | 34 |
|
|
2026
Q1 | $5.09M | Sell |
23,421
-609
| -3% | -$135K | 0.44% | 35 |
|
|
2025
Q4 | $5.49M | Sell |
24,030
-1,445
| -6% | -$329K | 0.46% | 33 |
|
|
2025
Q3 | $5.9M | Sell |
25,475
-1,376
| -5% | -$280K | 0.51% | 29 |
|
|
2025
Q2 | $4.98M | Buy |
26,851
+19
| +0.1% | +$3.53K | 0.47% | 35 |
|
|
2025
Q1 | $5.62M | Sell |
26,832
-847
| -3% | -$165K | 0.6% | 29 |
|
|
2024
Q4 | $4.92M | Sell |
27,679
-18
| -0.1% | -$3.31K | 0.51% | 35 |
|
|
2024
Q3 | $5.47M | Buy |
27,697
+143
| +0.5% | +$26.7K | 0.61% | 32 |
|
|
2024
Q2 | $4.73M | Sell |
27,554
-1,789
| -6% | -$296K | 0.57% | 33 |
|
|
2024
Q1 | $5.34M | Sell |
29,343
-197
| -0.7% | -$34K | 0.69% | 28 |
|
|
2023
Q4 | $4.58M | Buy |
29,540
+106
| +0.4% | +$15.5K | 0.66% | 27 |
|
|
2023
Q3 | $4.39M | Sell |
29,434
-78
| -0.3% | -$11.5K | 0.72% | 25 |
|
|
2023
Q2 | $3.98M | Sell |
29,512
-64
| -0.2% | -$9.38K | 0.63% | 31 |
|
|
2023
Q1 | $4.71M | Buy |
29,576
+98
| +0.3% | +$15K | 0.83% | 27 |
|
|
2022
Q4 | $4.76M | Buy |
29,478
+77
| +0.3% | +$11.8K | 0.95% | 25 |
|
|
2022
Q3 | $3.95M | Sell |
29,401
-402
| -1% | -$57.7K | 0.86% | 23 |
|
|
2022
Q2 | $4.57M | Sell |
29,803
-216
| -0.7% | -$33K | 0.97% | 23 |
|
|
2022
Q1 | $4.87M | Buy |
30,019
+50
| +0.2% | +$7.26K | 0.88% | 22 |
|
|
2021
Q4 | $4.06M | Buy |
29,969
+80
| +0.3% | +$9.45K | 0.72% | 26 |
|
|
2021
Q3 | $3.22M | Sell |
29,889
-45
| -0.2% | -$5.14K | 0.64% | 33 |
|
|
2021
Q2 | $3.37M | Buy |
29,934
+226
| +0.8% | +$25.5K | 0.67% | 31 |
|
|
2021
Q1 | $3.21M | Buy |
29,708
+189
| +0.6% | +$20.2K | 0.73% | 29 |
|
|
2020
Q4 | $3.06M | Buy |
29,519
+1,045
| +4% | +$100K | 0.7% | 28 |
|
|
2020
Q3 | $2.64M | Sell |
28,474
-175
| -0.6% | -$16.5K | 0.73% | 33 |
|
|
2020
Q2 | $2.65M | Buy |
28,649
+205
| +0.7% | +$18K | 0.83% | 29 |
|
|
2020
Q1 | $2.32M | Sell |
28,444
-118
| -0.4% | -$10.1K | 0.9% | 31 |
|
|
2019
Q4 | $2.51M | Sell |
28,562
-238
| -0.8% | -$19.8K | 0.84% | 34 |
|
|
2019
Q3 | $2.39M | Buy |
28,800
+13
| +0% | +$891 | 0.9% | 34 |
|
|
2019
Q2 | $2.05M | Sell |
28,787
-863
| -3% | -$67.8K | 0.84% | 39 |
|
|
2019
Q1 | $2.39M | Buy |
29,650
+10,307
| +53% | +$843K | 1.05% | 28 |
|
|
2018
Q4 | $1.78M | Buy |
+19,343
| New | +$1.7M | 0.99% | 30 |
|
Other funds holding ABBV
Means Investment Company's ABBV Position: Q2 2026 in Review
Means Investment Company reduced its AbbVie (ABBV) stake by 2.2% in Q2 2026, selling an estimated $110K and leaving 22,908 shares worth $5.76M. The position accounts for 0.44% of the portfolio, ranked #34.
Means Investment Company first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $5.9M in Q3 2025. 4,227 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Means Investment Company held 22,908 shares of AbbVie worth $5.76M as of Q2 2026.
- Means Investment Company sold 513 AbbVie shares in Q2 2026, an estimated $110K.
- AbbVie made up 0.44% of Means Investment Company's portfolio in Q2 2026, its #34 holding.
- Means Investment Company first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- Means Investment Company's AbbVie position peaked at $5.9M in Q3 2025.
- 4,227 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Means Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.